Should we still be using hydroxyethyl starch?
Nov 11, 2014•16 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Large trials show that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. So why does the European Medicines Agency still allow its use?
Helen Macdonald, analysis editor for The BMJ, discusses the issue with Christiane Hartog, a lecturer in intensive care medicine at Jena University Hospital in Germany, and one of the authors of an analysis paper on thebmj.com
Read the full analysis paper:
For the best experience, listen in Metacast app for iOS or Android